Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma

Cancer Research

Volumn 58, Issue 12, 1998, Pages 2624-2632

  Easton, John ^a   Wei, Tie ^a   Lahti, Jill M ^a   Kidd, Vincent J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; GENE PRODUCT; PROTEIN P16; PROTEIN P18; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; ENZYME INHIBITION; GENE MUTATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P19; CYCLIN-DEPENDENT KINASES; CYCLINS; HUMANS; MUTATION; NEOPLASM PROTEINS; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN-SERINE-THREONINE KINASES; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032525883     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Brodeur, G. M., Azar, C., Brother, M., Hiemstra, J. L., Kaurman, B., Marshall, H., Moley, J., Nakagawara, A., Saylors, R., Scavard, N., Schneider, S., Wasson, J., White, P., Seeger, R., Look, A. T., and Castleberry, R. P. Neuroblastoma: effect of genetic factors on prognosis and treatment. Cancer (Phila.), 70: 1685-1694, 1992.
2. Caron, H. N. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic makers in neuroblastoma. Med. Pediatr. Oncol., 24: 215-221, 1995.
3. Amati, B., Littlewood, T. D., Evan, G. I., and Land, H. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J., 12: 5083-5087, 1993.
4. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
5. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
6. Henriksson, M., and Luscher, B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res., 68: 109-182, 1996.
7. Packham, G., Porter, C. W., and Cleveland, J. L. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene, 13: 461-469, 1996.
8. Diccianni, M. B., Chau, L. S., Batova, A., Vu, T. Q., and Yu, A. L. The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance. Cancer Lett., 104: 183-192, 1996.
9. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
10. Ink4A-mediated growth suppression. Mol. Cell. Biol., 16: 1047-1057, 1996.
11. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
12. He, J., Allen, J. R., Collins, V. P., Allalunis-Turner, M. J., Godbout, R., Day, R. S., and James, C. D. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res., 54: 5804-5807, 1994.
13. INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res., 55: 4833-4836, 1995.
14. Khatib, Z. A., Matsushime, H., Valentine, M., Shapiro, D. N., Sherr, C. J., and Look, A. T. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res., 53: 5535-5541, 1993.
15. Koh, J., Enders, G. H., Dynlacht, B. D., and Harlow, E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (Lond.), 375: 506-510, 1995.
16. Ink4a requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA, 92: 6289-6293, 1995.
17. Nobori, T., Miura, K., Wu, D-J., Lois, A., Takabayashi, K., and Carson, D-A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.
18. Ink4b/MTS1 in pediatric acute lymphoblastic leukemia. Blood, 85: 2321-2331, 1995.
19. INK4/MTS1 tumour suppressor gene product. EMBO J., 14: 503-511, 1995.
20. INK4 function. Nat. Genet., 10: 114-116, 1995.
21. Reed, J. A., Loganzo, F., Shea, C. R., Walker, G. J., Flores, J. F., Glendening, J. M., Bogdany, J. K., Shiel, M. J., Haluska, F. G., Fountain, J. W., and Albino, A. P. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res., 55: 2713-2718, 1995.
22. Ink4a and of hypophosphorylated retinoblastoma family proteins. EMBO J., 16: 5322-5333, 1997.
23. 1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene, 15: 1347-1356, 1997.
24. 1 control. Cancer Res., 55: 4818-4823, 1995.
25. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Stauss, M., Peters, G., and Bartek, J. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (Lond.), 375: 503-506, 1995.
26. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Washington DC), 269: 1281-1284, 1995.
27. Lahti, J. M., Valentine, M., Xiang, J., Joens, B., Amann, J., Grenet, J., Richmond, G., Look, A. T., and Kidd, V. J. Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nat. Genet., 7: 370-375, 1994.
28. Scholer, H. R., Hatzopoulos, A. K., Balling, R., Suzuki, N., and Gruss, P. A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J., 8: 2543-2550, 1989.
29. Hiebert, S., Lipp, M., and Nevins, J. R. E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc. Natl. Acad. Sci. USA, 86: 3594-3598, 1989.
30. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., and Dracopoli, N. C. Germline p16 mutations in familial melanoma. Nat. Genet., 8: 15-21, 1994.
31. INK4c in tumor-derived cell lines and primary tumors. Oncogene, 12: 451-455, 1996.
32. ink4a binding domain of CDK4 in familial melanoma. Nat. Genet., 12: 97-99, 1996.
33. Kato, J., Matsushime, H., Hiebert, S. W., Ewen, M. E., and Sherr, C. J. Direct binding of cyclin D to the retinoblastoma gene product (pRb and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev., 7: 331-342, 1993.
34. Lew, D. J., Dulic, V., and Reed, S. I. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell, 66: 1197-1206, 1991.
35. 1-to-S phase transition. Mol. Cell. Biol. 15: 2612-2624, 1995.
36. Beltinger, C. P., White, P. S., Sulman, E. P., Maris, J. M., and Brodeur, G. M. No CDKN2 mutations in neuroblastoma. Cancer Res., 55: 2053-2055, 1995.
37. Liu, Q., Neuhausen, S., McClure, M., Frye, C., Weaver-Feldhaus, J., Gruis, N. A., Eddington, K., Allalunis-Turner, M. J., Skolnick, M. H., Fujimura, F. K., and Kamb, A. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene, 10: 1061-1067, 1995.
38. Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J., and Livingston, D. M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73: 487-497, 1993.
39. Roussel, M. F., Theodoras, A. M., Pagano, M., and Sherr, C. J. Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl. Acad. Sci. USA, 92: 6837-6841, 1995.
40. 1 cyclin-cdk complexes. EMBO J., 14: 4814-4826, 1995.
41. Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., and Barrett, J. C. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA, 93: 13742-13747, 1996.
42. Lois, A. F., Cooper, L. T., Geng, Y., Nobori, T., and Carson, D. Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation. Cancer Res., 55: 4010-4013, 1995.
43. INK4a. Cell, 88: 593-602, 1997.
44. Costello, J. F., Plass, C., Arap, W., Chapman, V. M., Held, W. A., Berger, M. S., Huang, H. S., and Cavenee, W. K. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res., 57: 1250-1254, 1997.
45. Suzuki, T., Kitao, S., Matsushime, H., and Yoshida, M. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J., 15: 1607-1614, 1996.
46. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.